We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-14.56%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$688M
AUM Growth
-$52M
Cap. Flow
-$179M
Cap. Flow %
-26.07%
Top 10 Hldgs %
65.57%
Holding
231
New
46
Increased
68
Reduced
48
Closed
42

Top Buys

Rank Stock Value
1
AIOS
AIOS Tech
AIOS
+$28.5M
2
AGMH icon
AGM Group Holdings
AGMH
+$13.2M
3
OG
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
+$7.66M
4
ESPR
Esperion Therapeutics
ESPR
+$7.53M
5
CNTX icon
Context Therapeutics
CNTX
+$6.14M

Top Sells

Rank Stock Value
1
ZNB
Zeta Network Group
ZNB
+$3.39M
2
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$3.33M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$3.06M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$2.84M
5
FLUX icon
Flux Power
FLUX
+$2.59M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.53%
2 Healthcare 8.91%
3 Financials 5.9%
4 Technology 5.82%
5 Consumer Discretionary 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCTXW
26
PUT
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$3.56M 0.52%
+4,301
New +$20.3K
RCON icon
27
Recon Technology
RCON
$548K
$3.53M 0.51%
748
+392
+110% +$2.89M
OG
28
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$3.33M 0.48%
+1,320,750
New +$7.66M
CNTX icon
29
Context Therapeutics
CNTX
$32.2M
$3.27M 0.48%
+1,230,830
New +$6.14M
TCDA
30
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
$3.15M 0.46%
3,298
+3,152
+2,159% +$20.3K
PMCB icon
31
PharmaCyte Biotech
PMCB
$4.83M
$3.04M 0.44%
1,217,828
+207,682
+21% +$572K
VRPX
32
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
$3.01M 0.44%
3,507
-465
-12% -$479K
AMRN
33
CALL
Amarin Corp
AMRN
$291M
$2.98M 0.43%
442
+30
+7% +$2.48K
BIVI icon
34
BioVie
BIVI
$17.3M
$2.92M 0.42%
6,482
+1,433
+28% +$828K
TANH icon
35
Tantech Holdings
TANH
$13.7M
$2.85M 0.41%
+13
New +$4.27M
MRTX
36
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.83M 0.41%
193
– –
RCAT icon
37
Red Cat Holdings
RCAT
$1.19B
$2.81M 0.41%
1,350,589
-8,796
-0.6% -$21.9K
CAN
38
Canaan Creative
CAN
$259M
$2.77M 0.4%
537,000
+289,071
+117% +$2.18M
ANY icon
39
PUT
Sphere 3D
ANY
$25.5M
$2.72M 0.4%
124
+51
+70% +$19.8K
ZSTK
40
ZeroStack Corp
ZSTK
$84.7M
$2.64M 0.38%
+1,900
New +$5.21M
VINC
41
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2.64M 0.38%
12,944
+2,944
+29% +$735K
AFIB
42
DELISTED
Acutus Medical Inc
AFIB
$2.54M 0.37%
745,600
+625,845
+523% +$3.52M
ZVRA icon
43
PUT
Zevra Therapeutics
ZVRA
$713M
$2.54M 0.37%
2,866
-46
-2% -$410
GPL
44
DELISTED
Great Panther Mining Limited
GPL
$2.52M 0.37%
+1,150,449
New +$3.91M
NBEV
45
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$2.47M 0.36%
2,395,153
+107,075
+5% +$141K
CING icon
46
Cingulate
CING
$73M
$2.45M 0.36%
+3,693
New +$2.61M
XWEL icon
47
PUT
XWELL
XWEL
$8.29M
$2.42M 0.35%
600
+3
+0.5% +$95
ATNM icon
48
PUT
Actinium Pharmaceuticals
ATNM
$44M
$2.4M 0.35%
4,001
+244
+6% +$1.83K
TKAT
49
DELISTED
Takung Art Co., Ltd.
TKAT
$2.34M 0.34%
576,729
-32,011
-5% -$179K
BIOR
50
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$2.27M 0.33%
+4,335
New +$3.11M
1
2
3 4 5

Similar funds

IWA
Independent Wealth Advisors Cary, North Carolina $111M AUM
BFA
Ballast Financial Advisors West Chester, Pennsylvania $110M AUM
WPWM
Western Pacific Wealth Management Lake Forest, Illinois $111M AUM 26.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
ZS
Zenith Solutions Philadelphia, Pennsylvania $110M AUM
KC
Karras Company Roy, Utah $110M AUM
FI
FinArc Investments Norwood, Massachusetts $110M AUM
CIM
Catalyst Investment Management Windham, New Hampshire $110M AUM

Sabby Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sabby Management held 231 positions worth $688M, down 7% from $740M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sabby Management withdrew a net $179M in Q4 2021, closing 42 positions and reducing 48 holdings. Its most notable exit was Tricida, Inc. Common Stock, an estimated $3.06M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, down from 77% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Sabby Management opened a new position in AIOS Tech worth $10.4M.

  • Sabby Management's largest Q4 2021 buy was AIOS Tech: 16,134 shares worth $10.4M.
  • Sabby Management added most to Acutus Medical Inc in Q4 2021, an estimated $3.52M increase.
  • Sabby Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.33M.
  • Sabby Management fully exited Tricida, Inc. Common Stock in Q4 2021, selling an estimated $3.06M.
  • Sabby Management's ten largest holdings make up 66% of its $688M portfolio in Q4 2021.
  • Sabby Management opened 46 new positions and closed 42 in Q4 2021.
  • Sabby Management's portfolio value fell 7% quarter-over-quarter to $688M.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.